Supplementary Figure 1. Burden of Illness & Outcomes in 2nd Line Large B-Cell Lymphoma Treatment: Real-world Analysis of Medicare Beneficiaries
figure
posted on 2021-10-20, 08:18 authored by Karl M. Kilgore, Iman Mohammadi, Anny C. Wong, Julia Thornton Snider, Paul Cheng, Amy Schroeder, Anik R. PatelSupplementary Figure 1. Overall Survival, Relative to Start of 2nd LOT, ASCT-Intended, Stratified by Time-to-Relapse
